A groundbreaking clinical trial, HBT-002, initiated by US-based biotechnology firm HealthBio, is poised to offer a new...
By Douglas Feil, NBCF Chief Program Officer In recent years, glucagon-like peptide-1 (GLP-1) receptor agonists have surged...
NEW YORK, NY — As the world turns pink every October for Breast Cancer Awareness Month, a...
TORONTO, ON – As medical advancements continue to improve breast cancer survival rates, the focus of the...
In a significant reinforcement of its global oncology strategy, Swiss pharmaceutical giant Roche has announced a major...
In a landmark achievement for genomic medicine, researchers at Newcastle University and The Newcastle upon Tyne Hospitals...
ROCKVILLE, Md. — For the millions of individuals living with rare genetic conditions, the path to a...
The Broad Institute of MIT and Harvard has long stood as a titan of genomic research and...
At the intersection of biotechnology and environmental stewardship, a quiet revolution is taking root in Huntsville, Alabama....
Published: October 22, 2026 In an era defined by perpetual motion and digital distraction, the pursuit of...
